Luzerne-Ortie
Natural health product licensed in Canada
- Other names
- Luzerne+Ortie Professional
- Licence holder
- Homeocan Inc.
- NPN or DIN-HM
- 80033454
- Status
- Active licence
- Licence date
- 6 July 2012
- Revision date
- 1 December 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Medicago sativa Source : Parties aériennes | 200 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hydroxypropyl methylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Utilisé en phytothérapie come tonique nutritif. L'ortie est utilisée en phytothérapie pour aider à soulager les symptômes d'allergies saisonnières, comme thérapie de soutien pour aider à soulager les douleurs rhumatismales et traditionnellement comme diurétique.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Ne pas utiliser en cas de grossesse ou d'allaitement. Ne pas utiliser si vous avez des antécédents de lupus érythémateux systémique.
Source
Official Health Canada record, licence 80033454
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging